Advances in Oncology and Radiotherapy
Advances in Oncology and Radiotherapy is a research topic within Radiology, Nuclear Medicine and Imaging. Science Explorer counts 23k research works in it since 1950. 6.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the global access to radiotherapy, including its role in cancer treatment, the expansion of access in low- and middle-income countries, workforce analysis, health economics, and infrastructure assessment. The papers also address the demand estimation for radiotherapy, medical education in oncology, and resource planning for optimal utilization.
- Radiotherapy
- Global Access
- Cancer Treatment
- Medical Education
- Health Economics
- Resource Planning
- Workforce Analysis
- Low- and Middle-Income Countries
- Infrastructure Assessment
- Demand Estimation
- Research works
- 23k fractional, since 1950
- In the world top 10%
- 1.6k per year above
- Top-10% rate
- 6.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +27% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Advances in Oncology and Radiotherapy research?
By volume, the United States and the United Kingdom publish the most (1.7k and 324 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.7k works
- 2 United Kingdom 324 works
- 3 India 197 works
- 4 Canada 193 works
- 5 China 164 works
- 6 Australia 137 works
- 7 Japan 123 works
- 8 Germany 116 works
- 9 Italy 104 works
- 10 France 97 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Advances in Oncology and Radiotherapy research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Advances in Oncology and Radiotherapy research, followed by Memorial Sloan Kettering Cancer Center and University of North Carolina at Chapel Hill.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 43 works
- 2 Memorial Sloan Kettering Cancer CenterUnited States 30 works
- 3 University of North Carolina at Chapel HillUnited States 25 works
- 4 University of California, San FranciscoUnited States 22 works
- 5 Stanford UniversityUnited States 22 works
- 6 Johns Hopkins UniversityUnited States 20 works
- 7 University of TorontoCanada 19 works
- 8 Harvard UniversityUnited States 19 works
- 9 Massachusetts General HospitalUnited States 17 works
- 10 University of Alabama at BirminghamUnited States 16 works
Who are the leading researchers in Advances in Oncology and Radiotherapy?
The most-cited researchers publishing on Advances in Oncology and Radiotherapy include Freddie Bray.
- 1 Freddie Bray France 4.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Advances in Oncology and Radiotherapy research done?
The largest centres of Advances in Oncology and Radiotherapy research in 2022–2025 are New York (United States), London (United Kingdom), Boston (United States) and Houston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Tampa.
Largest cities, 2022–2025
- 1 New York United States 102 works
- 2 London United Kingdom 102 works
- 3 Boston United States 70 works
- 4 Houston United States 64 works
- 5 Philadelphia United States 58 works
- 6 Toronto Canada 55 works
- 7 Chicago United States 46 works
- 8 Baltimore United States 41 works
- 9 Cleveland United States 36 works
- 10 Melbourne Australia 34 works
Where it is the local speciality
- TampaUS · 20.9 works7.1×
Location quotient: how much more of its research is in Advances in Oncology and Radiotherapy than the world average.
Where is the best place to study Advances in Oncology and Radiotherapy?
Among universities, judged by research, University of California, San Francisco, University of Alabama at Birmingham and Icahn School of Medicine at Mount Sinai score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of California, San FranciscoUnited States | 56.5 | 7.9% | 8.4× | 22 | +68.1% |
| 2 | University of Alabama at BirminghamUnited States | 54.0 | 10.0% | 8.1× | 16 | +72.2% |
| 3 | Icahn School of Medicine at Mount SinaiUnited States | 47.9 | 4.9% | 6.7× | 14 | +221.3% |
| 4 | Duke UniversityUnited States | 46.5 | 11.6% | 4.7× | 14 | +90.9% |
| 5 | Harvard UniversityUnited States | 45.0 | 9.8% | 3.6× | 19 | +71.0% |
| 6 | Johns Hopkins UniversityUnited States | 43.9 | 10.1% | 4.4× | 20 | +18.5% |
| 7 | University College LondonUnited Kingdom | 43.3 | 15.9% | 1.7× | 10 | +78.9% |
| 8 | Washington University in St. LouisUnited States | 42.7 | 13.6% | 4.5× | 13 | -2.6% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 42.2 | 17.2% | 2.4× | 10 | +52.5% |
| 10 | University of TorontoCanada | 40.9 | 6.8% | 3.3× | 20 | +100.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Advances in Oncology and Radiotherapy research growing?
Output in 2018–2022 was 27% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Advances in Oncology and Radiotherapy.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.